Literature DB >> 19277903

Disorders of the genome architecture: a review.

Dhavendra Kumar1.   

Abstract

Genetic diseases are recognized to be one of the major categories of human disease. Traditionally genetic diseases are subdivided into chromosomal (numerical or structural aberrations), monogenic or Mendelian diseases, multifactorial/polygenic complex diseases and mitochondrial genetic disorders. A large proportion of these conditions occur sporadically. With the advent of newer molecular techniques, a number of new disorders and dysmorphic syndromes are delineated in detail. Some of these conditions do not conform to the conventional inheritance patterns and mechanisms are often complex and unique. Examples include submicroscopic microdeletions or microduplications, trinucleotide repeat disorders, epigenetic disorders due to genomic imprinting, defective transcription or translation due to abnormal RNA patterning and pathogenic association with single nucleotide polymorphisms and copy number variations. Among these several apparently monogenic disorders result from non-allelic homologous recombination associated with the presence of low copy number repeats on either side of the critical locus or gene cluster. The term 'disorders of genome architecture' is alternatively used to highlight these disorders, for example Charcot-Marie-Tooth type IA, Smith-Magenis syndrome, Neurofibromatosis type 1 and many more with an assigned OMIM number. Many of these so called genomic disorders occur sporadically resulting from largely non-recurrent de novo genomic rearrangements. Locus-specific mutation rates for genomic rearrangements appear to be two to four times greater than nucleotide-specific rates for base substitutions. Recent studies on several disease-associated recombination hotspots in male-germ cells indicate an excess of genomic rearrangements resulting in microduplications that are clinically underdiagnosed compared to microdeletion syndromes. Widespread application of high-resolution genome analyses may offer to detect more sporadic phenotypes resulting from genomic rearrangements involving de novo copy number variation.

Entities:  

Year:  2009        PMID: 19277903      PMCID: PMC2694859          DOI: 10.1007/s11568-009-9028-2

Source DB:  PubMed          Journal:  Genomic Med        ISSN: 1871-7934


  29 in total

1.  The double helix in clinical practice.

Authors:  John I Bell
Journal:  Nature       Date:  2003-01-23       Impact factor: 49.962

Review 2.  Genomic rearrangements and sporadic disease.

Authors:  James R Lupski
Journal:  Nat Genet       Date:  2007-07       Impact factor: 38.330

3.  Triplication of 15q11-q13 with inv dup(15) in a female with developmental delay.

Authors:  F L Long; D P Duckett; L J Billam; D K Williams; J A Crolla
Journal:  J Med Genet       Date:  1998-05       Impact factor: 6.318

4.  Characterization of Potocki-Lupski syndrome (dup(17)(p11.2p11.2)) and delineation of a dosage-sensitive critical interval that can convey an autism phenotype.

Authors:  Lorraine Potocki; Weimin Bi; Diane Treadwell-Deering; Claudia M B Carvalho; Anna Eifert; Ellen M Friedman; Daniel Glaze; Kevin Krull; Jennifer A Lee; Richard Alan Lewis; Roberto Mendoza-Londono; Patricia Robbins-Furman; Chad Shaw; Xin Shi; George Weissenberger; Marjorie Withers; Svetlana A Yatsenko; Elaine H Zackai; Pawel Stankiewicz; James R Lupski
Journal:  Am J Hum Genet       Date:  2007-02-26       Impact factor: 11.025

5.  Global variation in copy number in the human genome.

Authors:  Richard Redon; Shumpei Ishikawa; Karen R Fitch; Lars Feuk; George H Perry; T Daniel Andrews; Heike Fiegler; Michael H Shapero; Andrew R Carson; Wenwei Chen; Eun Kyung Cho; Stephanie Dallaire; Jennifer L Freeman; Juan R González; Mònica Gratacòs; Jing Huang; Dimitrios Kalaitzopoulos; Daisuke Komura; Jeffrey R MacDonald; Christian R Marshall; Rui Mei; Lyndal Montgomery; Kunihiro Nishimura; Kohji Okamura; Fan Shen; Martin J Somerville; Joelle Tchinda; Armand Valsesia; Cara Woodwark; Fengtang Yang; Junjun Zhang; Tatiana Zerjal; Jane Zhang; Lluis Armengol; Donald F Conrad; Xavier Estivill; Chris Tyler-Smith; Nigel P Carter; Hiroyuki Aburatani; Charles Lee; Keith W Jones; Stephen W Scherer; Matthew E Hurles
Journal:  Nature       Date:  2006-11-23       Impact factor: 49.962

Review 6.  Genomic disorders: structural features of the genome can lead to DNA rearrangements and human disease traits.

Authors:  J R Lupski
Journal:  Trends Genet       Date:  1998-10       Impact factor: 11.639

7.  DNA rearrangements on both homologues of chromosome 17 in a mildly delayed individual with a family history of autosomal dominant carpal tunnel syndrome.

Authors:  L Potocki; K S Chen; T Koeuth; J Killian; S T Iannaccone; S K Shapira; C D Kashork; A S Spikes; L G Shaffer; J R Lupski
Journal:  Am J Hum Genet       Date:  1999-02       Impact factor: 11.025

8.  Deletions of NF1 gene and exons detected by multiplex ligation-dependent probe amplification.

Authors:  A De Luca; I Bottillo; M C Dasdia; A Morella; V Lanari; L Bernardini; L Divona; S Giustini; L Sinibaldi; A Novelli; I Torrente; A Schirinzi; B Dallapiccola
Journal:  J Med Genet       Date:  2007-12       Impact factor: 6.318

9.  Germline rates of de novo meiotic deletions and duplications causing several genomic disorders.

Authors:  Daniel J Turner; Marcos Miretti; Diana Rajan; Heike Fiegler; Nigel P Carter; Martyn L Blayney; Stephan Beck; Matthew E Hurles
Journal:  Nat Genet       Date:  2007-12-02       Impact factor: 38.330

Review 10.  Genomic disorders: molecular mechanisms for rearrangements and conveyed phenotypes.

Authors:  James R Lupski; Pawel Stankiewicz
Journal:  PLoS Genet       Date:  2005-12       Impact factor: 5.917

View more
  10 in total

Review 1.  Cognitive, behavioural and psychiatric phenotype in 22q11.2 deletion syndrome.

Authors:  Nicole Philip; Anne Bassett
Journal:  Behav Genet       Date:  2011-05-15       Impact factor: 2.805

2.  Etiological analysis of neurodevelopmental disabilities: single-center eight-year clinical experience in south China.

Authors:  Li Guo; Bing-Xiao Li; Mei Deng; Fang Wen; Jian-Hui Jiang; Yue-Qiu Tan; Yuan-Zong Song; Zhen-Huan Liu; Chun-Hua Zhang; Keiko Kobayashi; Zi-Neng Wang
Journal:  J Biomed Biotechnol       Date:  2010-09-26

3.  Drosophila Model for the Analysis of Genesis of LIM-kinase 1-Dependent Williams-Beuren Syndrome Cognitive Phenotypes: INDELs, Transposable Elements of the Tc1/Mariner Superfamily and MicroRNAs.

Authors:  Elena V Savvateeva-Popova; Aleksandr V Zhuravlev; Václav Brázda; Gennady A Zakharov; Alena N Kaminskaya; Anna V Medvedeva; Ekaterina A Nikitina; Elena V Tokmatcheva; Julia F Dolgaya; Dina A Kulikova; Olga G Zatsepina; Sergei Y Funikov; Sergei S Ryazansky; Michail B Evgen'ev
Journal:  Front Genet       Date:  2017-09-20       Impact factor: 4.599

4.  Saturation of the human phenome.

Authors:  Mark E Samuels
Journal:  Curr Genomics       Date:  2010-11       Impact factor: 2.236

5.  iSVP: an integrated structural variant calling pipeline from high-throughput sequencing data.

Authors:  Takahiro Mimori; Naoki Nariai; Kaname Kojima; Mamoru Takahashi; Akira Ono; Yukuto Sato; Yumi Yamaguchi-Kabata; Masao Nagasaki
Journal:  BMC Syst Biol       Date:  2013-12-13

6.  Copy number variations in a population-based study of Charcot-Marie-Tooth disease.

Authors:  Helle Høyer; Geir J Braathen; Anette K Eek; Gry B N Nordang; Camilla F Skjelbred; Michael B Russell
Journal:  Biomed Res Int       Date:  2015-01-08       Impact factor: 3.411

Review 7.  Advances in understanding - genetic basis of intellectual disability.

Authors:  Pietro Chiurazzi; Filomena Pirozzi
Journal:  F1000Res       Date:  2016-04-07

8.  Pysim-sv: a package for simulating structural variation data with GC-biases.

Authors:  Yuchao Xia; Yun Liu; Minghua Deng; Ruibin Xi
Journal:  BMC Bioinformatics       Date:  2017-03-14       Impact factor: 3.169

9.  The investigation for potential modifier genes in patients with neurofibromatosis type 1 based on next-generation sequencing.

Authors:  Fan Yang; Song Xu; Renwang Liu; Tao Shi; Xiongfei Li; Xuebing Li; Gang Chen; Hongyu Liu; Qinghua Zhou; Jun Chen
Journal:  Onco Targets Ther       Date:  2018-02-21       Impact factor: 4.147

10.  miRNA-mediated risk for schizophrenia in 22q11.2 deletion syndrome.

Authors:  Linda M Brzustowicz; Anne S Bassett
Journal:  Front Genet       Date:  2012-12-13       Impact factor: 4.599

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.